[Upcoming Lecture] Antimicrobial Resistance (AMR) Seminar: Lessons from Semmelweis (Japan Medical Association office, Tokyo, Bunkyo-ku, November 22, 2019)
date : 11/5/2019
HGPI and its co-hosts the Japan Pharmaceutical Manufacturers Association(JPMA) and Japan Medical Association (JMA) will host a lecture aimed at healthcare providers, representatives from the government, and members of civil society entitled “Antimicrobial Resistance (AMR) Seminar: Lessons from Semmelweis.”
HGPI Chairman Dr. Kiyoshi Kurokawa will speak on the theme “The History of Infectious Disease and Current Challenges – Lessons from the Teachings of Semmelweis” and Adjunct Fellow Ms. Kaoru Matsuzawa and HGPI Board Member and CEO Mr. Ryoji Noritake will serve as moderators for a panel discussion.
■Program
Date & Time: Friday, November 22, 2019, 14:00-17:00 (Doors open at 13:30)
Venue: Japan Medical Association Office , Small Auditorium
Participation fee: Free
Capacity: 200 people
For program details, please see the PDF linked below.
To register, please fax or mail the registration form included in the PDF. To register online, please see the AMR Seminar website.
*It can be accessed in Japanese.
Top Research & Recommendations Posts
- [Policy Recommendations] Improving Patient Access to Genomic Cancer Medicine (August 10, 2023)
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Public Comment Submission] “The 7th Science, Technology and Innovation Basic Plan” (Draft) (February 19, 2026)
- [Event Report and Discussion Points] AI Diagnostic Support Project Expert Meeting: “The Roles of Industry, Government, Academia, and Civil Society in the Era of AI-Assisted Diagnosis” (May 25, 2026)
- [Policy Recommendations] Policy Recommendations in the Field of Blood Disorders “Building a Healthcare Ecosystem Centered on Patients and Those Affected” (April 13, 2026)
- [Announcement] Signs Health Policy Recommendations to the G7 by the C7 Global Health Working Group (March 30, 2026)
- [Research Report] The 2026 Public Opinion Survey on Healthcare in Japan (February 13, 2026)
Featured Posts
-
2026-05-13
[Registration Open] HGPI Salon 2025-2026 Looking Ahead to the Future of Japan’s Social Security System “Session 5: The Value of Healthcare in Society – Perspectives from the Reiwa Era” (June 29, 2026)
-
2026-06-04
[Registration Open] (Webinar) The 3rd J-PEP Seminar “Social Participation of People with Intractable Diseases and the Potential of a New Way of Working — ‘RD Workers’ — Lessons from Policy Advocacy Practice” (July 22, 2026)
-
2026-06-15
[Registration Open] (Hybrid Format) Multidisciplinary Symposium for Cardiology, Nephrology, and Metabolic Medicine “Future Actions for Making Full Use of the Health Checkup System: Connecting Checkups to Treatment From the Perspective of Data Linkage” (July 6, 2026)
-
2026-06-19
[Recommendations] Strengthening Epidemiology Education in the Veterinary Field for the One Health Era (June 19, 2026)
-
2026-06-24
[Policy Recommendations] Joint Statement “Protecting the Health of Both the Planet and People — A Japan-Model Planetary Health Strategy to Turn the Climate Crisis into an Opportunity for Health, the Economy, and Growth” (June 24, 2026)



